MATERION Corp (MTRN) CFO exercises 4,972 SARs and sells 1,705 shares
Rhea-AI Filing Summary
MATERION Corp Vice President, Finance & CFO Shelly Marie Chadwick exercised stock appreciation rights into 4,972 shares of common stock on August 7, 2026, including 2,800 shares at an exercise price of $135.58 and 2,172 shares at $87.36. On the same date, 3,267 shares of common stock were delivered or withheld for payment of exercise price or tax liability, and 1,705 shares were sold at $293.00 per share.
Positive
- None.
Negative
- None.
Insider Trade Summary
Exercise and sale activity reported; no spread calculated
Exercise and Sale
6 txns
Insider
Chadwick Shelly Marie
Role
Vice President, Finance & CFO
Sold
1,705 shs ($500K)
Approx. gross sale proceeds
$500K
Approx. exercise cost
$569K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Appreciation Rights F1 | 2,800 | $0.00 | $0.00 |
| Exercise | Stock Appreciation Rights F2 | 2,172 | $0.00 | $0.00 |
| Exercise | Common Stock | 2,800 | $135.58 | $380K |
| Exercise | Common Stock | 2,172 | $87.36 | $190K |
| Exercise Price or Tax Liability | Common Stock | 3,267 | $293.40 | $959K |
| Sale | Common Stock | 1,705 | $293.00 | $500K |
Holdings After Transaction:
Stock Appreciation Rights — 5,745 shares (Direct);
Common Stock — 15,246 shares (Direct)
Footnotes (2)
- F1. The Stock Appreciation Rights vest in three substantially equal annual installments beginning March 1, 2025.
- F2. The Stock Appreciation Rights vest in three substantially equal annual installments beginning March 1, 2026.
Key Figures
Exercised SARs (grant 1): 2,800 Stock Appreciation Rights at $135.58
Exercised SARs (grant 2): 2,172 Stock Appreciation Rights at $87.36
Shares withheld/delivered for exercise price or tax liability: 3,267 shares at $293.40
+2 more
5 metrics
Exercised SARs (grant 1)
2,800 Stock Appreciation Rights at $135.58
Exercised into 2,800 shares of common stock on August 7, 2026
Exercised SARs (grant 2)
2,172 Stock Appreciation Rights at $87.36
Exercised into 2,172 shares of common stock on August 7, 2026
Shares withheld/delivered for exercise price or tax liability
3,267 shares at $293.40
Common shares delivered or withheld in code F transaction on August 7, 2026
Shares sold
1,705 shares at $293.00
Common stock sale (code S) on August 7, 2026
Total SARs exercised
4,972 Stock Appreciation Rights
Sum of derivative exercises (code M) reported in this Form 4
Key Terms
Stock Appreciation Rights, exercise price or tax liability, substantially equal annual installments
3 terms
Stock Appreciation Rights financial
"The Stock Appreciation Rights vest in three substantially equal annual installments"
Stock appreciation rights (SARs) are a form of employee compensation that give the holder the right to receive the increase in a company's stock price over a set baseline, paid in cash or shares, without having to buy the stock. For investors, SARs matter because they can create future cash outflows or share dilution and signal how a company rewards and motivates executives — similar to giving a bonus tied directly to how well the company’s stock performs.
exercise price or tax liability financial
"Payment of exercise price or tax liability by delivering or withholding securities"
substantially equal annual installments financial
"vest in three substantially equal annual installments beginning March 1, 2025"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What did MATERION Corp (MTRN) CFO Shelly Marie Chadwick report in this Form 4?
Shelly Marie Chadwick reported exercising 4,972 stock appreciation rights into common shares and related dispositions on August 7, 2026, including shares delivered or withheld for exercise price or tax liability and an open-market sale of common stock.
How many MTRN stock appreciation rights did the CFO exercise and at what prices?
The CFO exercised 4,972 stock appreciation rights, consisting of 2,800 rights at $135.58 per share and 2,172 rights at $87.36 per share, each converting into the same number of common shares of MATERION Corp.
Were the MTRN CFO’s Form 4 transactions under a Rule 10b5-1 trading plan?
The document-level indicator shows the Rule 10b5-1 checkbox is not marked as affirmative (aff_10b5_one: false), meaning these reported transactions are not designated in the filing as being made under a Rule 10b5-1 trading plan.
What vesting terms apply to the MTRN CFO’s stock appreciation rights that were exercised?
Footnotes state the stock appreciation rights vest in three substantially equal annual installments, with one grant beginning on March 1, 2025 and another beginning on March 1, 2026, providing context for when the exercised rights became vested.